Lung cancer trial has problems in recruitmentBMJ 2000; 321 doi: http://dx.doi.org/10.1136/bmj.321.7255.195/a (Published 22 July 2000) Cite this as: BMJ 2000;321:195
- Susan Mayor
Nearly three quarters of patients eligible to take part in a UK trial of chemotherapy in non-small cell lung cancer have declined to take part, according to a study published last week that showed fear of side effects to be a major factor in patients' decisions.
The big lung trial (BLT) aims to assess the effectiveness of chemotherapy in treating all stages of non-small cell lung cancer. Lead researcher Stephen Spiro, professor of respiratory medicine …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial